Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

PKR activator 3

Inquiry
Cat. No.: OB0425LY-252
Synonyms: 1628428-01-2; N-[4-[4-Hydroxy-4-(2-methylpropyl)piperidine-1-carbonyl]phenyl]quinoxaline-5-sulfonamide; 5-Quinoxalinesulfonamide, N-(4-((4-hydroxy-4-(2-methylpropyl)-1-piperidinyl)carbonyl)phenyl)-; N-(4-((4-Hydroxy-4-(2-methylpropyl)-1-piperidinyl)carbonyl)phenyl)-5-quinoxalinesulfonamide
Size: 1 mg; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg
CAS No.: 1628428-01-2
Compound CID: 86295470
PKR activator 3

Specification

Description: PKR activator 3 is a small molecule compound primarily used to activate protein kinase R (PKR).
Formula Weight: 468.57
Applications: PKR activator 3 can be used to study diseases related to PKR function, including cancer, diabetes, and obesity.
Storage: Storage at -20°C.
Formula: C24H28N4O4S
Appearance: Solid
Purity: 99.87%, determined by LC-MS.
Solubility: DMSO
Pathway: Metabolic enzyme/Protease
Identity: Confirmed by LC-MS.
Target: Pyruvate kinase

Library Information

Solubility: DMSO
Inquiry

Copyright © Protheragen. All rights reserves.